期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

子宫颈癌相关抑癌基因的研究新进展 被引量：4

下载PDF
导出
摘要 宫颈癌是最常见的妇科恶性肿瘤之一，严重威胁到女性的健康与生命。宫颈癌的发病是一个多基因、多步骤的结果，其中抑癌基因功能的丧失和癌基因的表达是其细胞癌变的分子基础。在已发现的数个抑癌基因中，p27、TSLC1、FHIT、nm23、RASSF1A等抑癌基因与宫颈癌关系密切。
作者 曹卫红 黄利鸣 王艳林
机构地区 三峡大学医学院分子生物研究所 三峡大学医学院病理学教研室
出处 《实用医学杂志》 CAS 北大核心 2010年第7期1248-1249,共2页 The Journal of Practical Medicine
基金 国家自然科学基金资助项目(编号:30873282)
关键词 抑癌基因功能 子宫颈癌 RASSF1A 妇科恶性肿瘤 TSLC1 分子基础 细胞癌变 FHIT
分类号 R737.33 [医药卫生—肿瘤]
  • 相关文献

参考文献19

  • 1Bilitou A, Watson J, Gartner A, et al. The NM23 family in development [J]. Mol Cell Biochem, 2009,329(1-2) : 17-33.
  • 2Boissan M, Dabernat S, Peuchant E, et al. The mammalian Nm23/NDPK family: from metastasis control to cilia movement [J]. Mol Cell Biochem, 2009,329 (1-2) : 51-62.
  • 3Branca M, Giorgi C, Ciotti M, et al. Down-regulated nucleoside diphosphate kinase nm23-H1 expression is unrelated to high-risk human papillomavirus but associated with progression of cervical intraepithelial neoplasia and unfavonrable prognosis in cervical cancer [J]. Eur J Gynaecol Oncol, 2006, 59 (10) : 1044- 1051.
  • 4罗淑桂,王祥珍,孙显斌.p16和nm23在宫颈癌组织中的表达及临床意义[J].中国实用妇科与产科杂志,2004,20(7):421-422. 被引量：7
  • 5Campiglio M, Bianchi F, Andriani F, et al. Diadenosines as FHIT-ness instructors [J]. J Cell Physiol,2006,208 (2):274- 281.
  • 6刘辉,彭芝兰,杨开选,刘珊玲,王和,张崇淑,范余娟,郑艾.FHIT蛋白表达下调与宫颈癌发生发展的关系[J].四川大学学报（医学版）,2004,35(6):846-848. 被引量：1
  • 7Ki K D, Lee S K, Tong S Y, et al. Role of 5'-CpG island hypermethylation of the FHIT gene in cervical carcinoma [J]. Gynecol Oncol, 2008,19(2) : 117-122.
  • 8Murakami Y. Involvement of a cell adhesion molecule, TSLC1/GSF4, in human oncogenesis [J]. Cancer Sci, 2005,96 ( 9 ) : 543-552.
  • 9Overmeer R M, Henken F E, Snijders P J, et al. Association between dense CADM1 promoter methylation and reduced protein expression in high-grade CIN and cervical SCC [ J ]. J Pathol, 2008,215 (4) : 388-397.
  • 10王卡娜,许飞雪,李红芳,杨爱宏,杨永秀.TSLC1基因异常甲基化及与HPV的关系在宫颈癌发生发展中的意义[J].现代妇产科进展,2009,18(2):94-98. 被引量：6

二级参考文献39

  • 1Kuramochi M, Fukuhara H, Nobukuni T, et al. TSLC1 is a tumor-suppressor gene in human non-small-cell lung cancer[ J]. Nat Genet,2001,27 :427-430
  • 2Fukami T, Fukuhara H, Kuramochi M, et al. Promoter methylation of the TSLC1 gene in advanced lung tumors and various cancer cell lines [ J ]. Int J Cancer, 2003, 107:53-59
  • 3Yoo CB, Jones PA. Epigenetic therapy of cancer: past, present and future[ J]. Nat Rev Drug Discov,2006,5:37- 50
  • 4Lung HL, Cheng Y, Kumaran MK, et al. Fine mapping of the 11 q22-23 tumor suppressive region and involvement of TSLC1 in nasopharyngeal carcinoma [ J ]. Int J Cancer, 2004,112:628-635
  • 5Ito T, Shimada Y, Hashimoto Y, et al. Involvement of TSLC1 in progression of esophageal squamous cell carcinoma [ J ]. Cancer Res,2003,63 : 6320-6326
  • 6Mehrotra J, Vali M, McVeigh M, et al. Very high frequency of hypermethylated genes in breast cancer metastasis to the bone, brain, and lung [ J ]. Clin Cancer Res, 2004, 10: 3104-3109
  • 7Fukuhara H, Kuramochi M, Fukami T, et al. Promoter methylation of TSLC1 and tumor suppression by its gene product in human prostate cancer[J]. Jpn J Cancer Res, 2002,93:605-609
  • 8Goelz SE, Hamilton SR, Vogelstein B. Purification of DNA from formaldehyde fixed and paraffin embedded human tissue[ J ]. Biochem Biophys Res Commun, 1985,130:118- 126
  • 9Ito A, Hagiyama M, Mimura T, et al. Expression of cell adhesion molecule 1 in malignant pleural mesothelioma as a cause of efficient adhesion and growth on mesothelium [ J]. Lab Invest,2008,88:504-514
  • 10Hong SM, Kelly D, Griffith M, et al. Multiple genes are hypermethylated in intraductal papillary mucinous neoplasms of the pancreas[J]. Mod Pathol,2008,21 : 1499- 1507

共引文献17

同被引文献42

  • 1李伟峰,徐虹,杜海坚,杜玮.p16基因异常甲基化检测对周围型肺癌的诊断价值[J].实用医学杂志,2006,22(5):530-532. 被引量：3
  • 2Jemal A, Siegel R, Ward E, et al. Cancer statistics[J]. CA Cancer J Clin, 2006, 56: 106- 130.
  • 3Krop I E, Sgroi D, Porter D A, et al. HIN-1, a putative cytokine highly expressed in normal but not cancerous mammary epithelial cells [J]. Proc Natl Acad Sci, 2001(98) 9796-9801.
  • 4Herman J G, Graft J R, Myohanen S, et al. Methylation- specific PCR: A novel PCR assay for methylation status of CpG islands [J]. Proe Natl Aead Sci, 1996(93):9821-9826.
  • 5Agathanggelou A, Honorio S, Maeartney D P, et al. Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumors [J]. Oncogene, 2001,20(8) : 1509-1518.
  • 6Curtis C D, Goggins M. DNA methylation analysis in human cancer [J]. Methods Mol Med, 2005,103( 1 ) : 123-136.
  • 7Herman J G, Baylin S B. Gene silencing in cancer in association with promoter hypermethylation[J]. N Engl J Med, 2005 (21): 2042-2054.
  • 8Zochbauer Muller S, Minna J D, Gazdar A F, et al. Aberrant DNA methylation in lung cancer: biological and clinical implications[J]. Oncologist, 2002,7 (5) : 451-457.
  • 9Jemal A, Siegel R, Ward E, et al. Cancer statistics [J]. CA Cancer J Clin, 2006, 56:106- 130.
  • 10Krop I E, Sgroi D, Porter D A, et al. HIN-1, a putative cytokine highly expressed in normal but not cancerous mammary epithelial cells [J]. Proc Natl Acad Sci, 2001 (98) 9796-9801.

引证文献4

二级引证文献10

实用医学杂志
2010年 第7期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部